220 related articles for article (PubMed ID: 23106811)
1. Integrative analysis of neuroblastoma and pheochromocytoma genomics data.
Szabó PM; Pintér M; Szabó DR; Zsippai A; Patócs A; Falus A; Rácz K; Igaz P
BMC Med Genomics; 2012 Oct; 5():48. PubMed ID: 23106811
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas.
Tömböl Z; Eder K; Kovács A; Szabó PM; Kulka J; Likó I; Zalatnai A; Rácz G; Tóth M; Patócs A; Falus A; Rácz K; Igaz P
Mod Pathol; 2010 Dec; 23(12):1583-95. PubMed ID: 20818339
[TBL] [Abstract][Full Text] [Related]
3. Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome.
Eisenhofer G; Huynh TT; Pacak K; Brouwers FM; Walther MM; Linehan WM; Munson PJ; Mannelli M; Goldstein DS; Elkahloun AG
Endocr Relat Cancer; 2004 Dec; 11(4):897-911. PubMed ID: 15613462
[TBL] [Abstract][Full Text] [Related]
4. How many pathways to pheochromocytoma?
Neumann HP; Hoegerle S; Manz T; Brenner K; Iliopoulos O
Semin Nephrol; 2002 Mar; 22(2):89-99. PubMed ID: 11891502
[TBL] [Abstract][Full Text] [Related]
5. Inherited pheochromocytoma.
Neumann HP; Bender BU; Januszewicz A; Janetschek G; Eng C
Adv Nephrol Necker Hosp; 1997; 27():361-76. PubMed ID: 9408456
[No Abstract] [Full Text] [Related]
6. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.
Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP
J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of erythropoietin and its receptor in von hippel-lindau-associated and multiple endocrine neoplasia type 2-associated pheochromocytomas.
Vogel TW; Brouwers FM; Lubensky IA; Vortmeyer AO; Weil RJ; Walther MM; Oldfield EH; Linehan WM; Pacak K; Zhuang Z
J Clin Endocrinol Metab; 2005 Jun; 90(6):3747-51. PubMed ID: 15769989
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.
Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR
Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490
[TBL] [Abstract][Full Text] [Related]
10. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.
Ritter MM; Frilling A; Crossey PA; Höppner W; Maher ER; Mulligan L; Ponder BA; Engelhardt D
J Clin Endocrinol Metab; 1996 Mar; 81(3):1035-7. PubMed ID: 8772572
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones.
Tsuchiya MI; Okuda H; Takaki Y; Baba M; Hirai S; Ohno S; Shuin T
Oncol Rep; 2005 Jun; 13(6):1033-41. PubMed ID: 15870918
[TBL] [Abstract][Full Text] [Related]
12. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
13. [Genetic tests in oncology practice with emphasis on the RET oncogene and VHL tumor suppressor gene].
Nesković G; Stanojević B; Palmar I; Dimitrijević B
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():52-7. PubMed ID: 12584999
[TBL] [Abstract][Full Text] [Related]
14. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG
J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma.
Hattori Y; Kanamoto N; Kawano K; Iwakura H; Sone M; Miura M; Yasoda A; Tamura N; Arai H; Akamizu T; Nakao K; Maitani Y
Int J Oncol; 2010 Sep; 37(3):695-705. PubMed ID: 20664939
[TBL] [Abstract][Full Text] [Related]
16. Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas.
Bender BU; Gutsche M; Gläsker S; Müller B; Kirste G; Eng C; Neumann HP
J Clin Endocrinol Metab; 2000 Dec; 85(12):4568-74. PubMed ID: 11134110
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of phenylethanolamine N-methyltransferase in pheochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Huynh TT; Pacak K; Wong DL; Linehan WM; Goldstein DS; Elkahloun AG; Munson PJ; Eisenhofer G
Ann N Y Acad Sci; 2006 Aug; 1073():241-52. PubMed ID: 17102092
[TBL] [Abstract][Full Text] [Related]
19. Pheochromocytoma: the expanding genetic differential diagnosis.
Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
[TBL] [Abstract][Full Text] [Related]
20. Bilateral pheochromocytomas and congenital anomalies associated with a de novo germline mutation in the von Hippel-Lindau gene.
Assadi F; Brackbill EL
Am J Kidney Dis; 2003 Jan; 41(1):E3. PubMed ID: 12500216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
